Members |
targetComponentId |
pramlintid 1 mg/ml, injektionsvätska, lösning, förfylld penna |
Pramlintide only product |
Pre-excitation atrioventricular conduction |
Accelerated atrioventricular conduction |
duplexvaccination mot difteri och stelkramp i förskoleåldern |
Preschool administration of diphtheria and tetanus vaccine |
Precautionary nursing procedure |
Nursing procedure |
Prediabetes |
Impaired glucose tolerance |
prednisolon 0,001 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
prednisolon 0,003 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,01 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,01 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,01 %, ögondroppar utan konserveringsmedel |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
prednisolon 0,03 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,03 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,03 %, ögondroppar utan konserveringsmedel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,1 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,1 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,1 %, ögondroppar utan konserveringsmedel |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
prednisolon 0,3 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,3 %, ögondroppar |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
prednisolon 0,3 %, ögondroppar utan konserveringsmedel |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
prednisolon 20 mg/100 ml, retentionslavemang som administreras med lång slang |
Prednisolone only product in rectal dose form |
prednisolon 20 mg/100 ml, retentionslavemang som administreras med standardslang |
Prednisolone only product in rectal dose form |
prednisolon 5 mg, löslig tablett |
Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug) |
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, salva |
Prednisolone and sulfacetamide only product in ocular dose form |
Prednisolone acetate 25mg/mL |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
prednisolonacetat 25 mg/ml, suspension |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
allergi mot prednisolondroppar |
Allergy to prednisolone |
prednisolonhexanoat 1,3 mg + cinkokain 1 mg, suppositorium |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
prednisolonnatriumfosfat 0,5 %, ögondroppar |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
prednisolonnatriumfosfat 0,5 %, ögondroppar för engångsbruk |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
prednisolonnatriumfosfat 1 %, lösning |
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
prednisolonnatriumfosfat 1/8 %, lösning |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
preferens för temperatur på dryck |
Preference for temperature of drink (observable entity) |
preferens för temperatur på mat |
Preference for temperature of food (observable entity) |
Preglaucoma |
Glaucoma suspect |
förlängd graviditet-41 veckor |
Prolonged pregnancy (disorder) |
förlängd graviditet-42 veckor |
Prolonged pregnancy (disorder) |
Pregnancy, childbirth and puerperal disorders |
Disorder of pregnancy |
Premature ejaculation |
Premature ejaculation |
underburet foster |
Prematurity of infant (disorder) |
Premenstrual tension |
Premenstrual tension syndrome |
Preoperative nursing procedure |
Preoperative care |
preoperativa åtgärder |
Preoperative procedure |
Preretinal fibrosis |
Epiretinal membrane |
Presence of complement |
Complement assay |
Presence of complement component 3 |
Complement assay |
Presence of complement component 4 |
Complement assay |
Presence of drugs of abuse |
Drug, confirmation assay |
Presence of heavy metal |
Heavy metal screen |
Presence of pesticide |
Pesticides screen |
Pressure on artery |
Pressure - action |
Pressure on limb artery |
Pressure - action |
trycksår |
Pressure injury |
trycksår kategori 1 |
Pressure injury stage I (disorder) |
trycksår kategori 2 |
Pressure injury stage II (disorder) |
trycksår kategori 3 |
Pressure injury stage III |
trycksår kategori 4 |
Pressure injury stage IV (disorder) |
Prevotella oulora |
Prevotella oulorum (organism) |
Prevotella ruminicola, underart rumnicola |
Prevotella ruminicola |
Prevotella zoogleoformans |
Bacteroides zoogleoformans (organism) |
prilokainhydroklorid 1 %, injektionsvätska, lösning, flaska |
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
prilokainhydroklorid 4 % + adrenalin 200 000, injektionsvätska, lösning, flaska |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
Primary ciliary dyskinesia |
Immotile cilia syndrome |
Primary closure |
Closure - action |
primärt kutant B-cellslymfom, kategori |
Primary cutaneous B-cell lymphoma |
primärt kutant T-cellslymfom, kategori |
Primary cutaneous T-cell lymphoma (morphologic abnormality) |
primärt kutant anaplastiskt storcelligt B-cellslymfom |
Primary cutaneous B-cell lymphoma (disorder) |
primärt kutant storcelligt T-cellslymfom, kategori |
Primary cutaneous large T-cell lymphoma |
Primary frambesia |
Initial lesion of yaws |
Primary malignant neoplastic process |
Malignant neoplasm, primary (morphologic abnormality) |
Primary papule of pinta |
Pinta, primary lesion |
Primary repair of torn capsule of knee, collateral |
Procedure on knee joint |
Primary repair of torn capsule of knee, cruciate |
Procedure on knee joint |
primär transvestism |
Primary transvestism (finding) |
Primate immunodeficiency virus |
Primate lentivirus group (organism) |
Probing - action |
Exploration - action |
probiotisk produkt |
Microbial agent (substance) |
prokainamidhydroklorid 250 mg, tablett med modifierad frisättning |
Procainamide only product in oral dose form |
prokainamidhydroklorid 250 mg, depåtablett |
Procainamide only product in oral dose form |
prokainamidhydroklorid 750 mg, tablett med modifierad frisättning |
Procainamide only product in oral dose form |
prokainamidhydroklorid 750 mg, depåtablett |
Procainamide only product in oral dose form |
Procaine hydrochloride 10% injection |
Procaine 100 mg/mL solution for injection |
prokainhydroklorid 10 %, injektionsvätska, lösning, flaska 2 ml |
Procaine 100 mg/mL solution for injection |
prokainhydroklorid 10 mg/ml (1 %), injektionsvätska, lösning, flaska |
Product containing precisely procaine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
bensylpenicillinprokainallergi |
Allergy to benzylpenicillin |
Procedure on anus |
Operation on anus |
Procedure on uvula (uvula palatina) |
Operation on uvula |
proklorperazinedisylat 5 mg/5 ml, sirap |
Prochlorperazine 1 mg/mL oral solution |
Prodigiosin |
Prodigiosin |
läkemedel som innehåller acetylkolin, intraokulär läkemedelsform |
Acetylcholine-containing product in parenteral dose form |
läkemedel som innehåller afamelanotid, subkutan läkemedelsform |
Product containing afamelanotide in parenteral dose form (medicinal product form) |
läkemedel som innehåller allantoin och koltjära |
Allantoin- and coal tar extract-containing product |
läkemedel som innehåller aluminium, för orofaryngealt bruk |
Aluminium-containing product in oromucosal dose form |
natriumaminosalicylat |
Product containing para-aminosalicylic acid (medicinal product) |
ammoniumtioglykolat |
Thioglycolic acid-containing product |
läkemedel som innehåller medel mot trypanosomiasis |
Antiprotozoal agent |
läkemedel som innehåller apomorfin, för orofaryngealt bruk |
Product containing apomorphine in oromucosal dose form (medicinal product form) |
läkemedel som innehåller askorbinsyra, för orofaryngealt bruk |
Product containing ascorbic acid in oromucosal dose form (medicinal product form) |
läkemedel som innehåller baloxavirmarboxil |
Baloxavir-containing product |
läkemedel som innehåller baloxavirmarboxil i oral läkemedelsform |
Baloxavir-containing product in oral dose form |